新五豐(600975.SH):陝西省國際信託股份減持期屆滿 累計減持1000股
格隆匯6月3日丨新五豐(600975.SH)公佈,2020年6月3日,公司收到陝西省國際信託股份有限公司(代陝國投•得壹五豐證券投資集合資金信託計劃)《告知函》,截止2020年6月2日,陝西省國際信託股份有限公司(代陝國投•得壹五豐證券投資集合資金信託計劃)通過集中競價交易方式共減持1000股,佔新五豐總股份的0.00015%,此次減持計劃尚未實施完畢,但減持時間區間屆滿。
截至2020年6月3日,陝西省國際信託股份有限公司(代陝國投•得壹五豐證券投資集合資金信託計劃)持有公司無限售條件流通股3263.28萬股,佔公司總股本比例4.99985%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.